home email sign-up search
HealthCast Calendar
Daily Reports Health Poll Search
Issue Spotlight
Daily Reports
Daily Health Policy Report
Daily HIV/AIDS Report
Weekly Health Disparities Report
First Edition
Search All Daily Reports Archives
 

Site Search

 

 

 



Kaiser Daily Women's Health Policy
  • Printer-Friendly Page
  • Email this Page
  • Share
  • Reprint
Opinion | Kaiser Daily Women's Health Policy Report Summarizes Editorials on Nonprescription Sales of Plan B
[Aug 08, 2006]

      Some editorials and an opinion piece respond to a July 31 letter to Barr Laboratories' subsidiary Duramed Research from FDA in which acting FDA Commissioner Andrew von Eschenbach wrote that the agency is reconsidering the company's application to allow Barr's emergency contraceptive to be sold without a prescription to girls and women ages 16 and older. The letter says that 18 is the "appropriate age" to allow women to buy Plan B without a prescription and asks Barr to raise the age restriction in its application from 16 to 18. The letter also requests that Barr meet with FDA within seven days, make unspecified changes to the packaging for Plan B and provide a thorough description of the company's plan to enforce the age restriction. FDA spokesperson Susan Bro said that Barr and FDA are scheduled to meet on Tuesday in Washington, D.C., to discuss the application (Kaiser Daily Women's Health Policy Report, 8/3). The editorials also respond to von Eschenbach's confirmation hearings in the Senate Health, Education, Labor and Pensions Committee, which began one day after the letter was sent to Barr. During the hearing, committee members questioned him regarding the agency's review of the application (Kaiser Daily Women's Health Policy Report, 8/2). Summaries appear below.

Editorials

  • South Florida Sun-Sentinel: "Politics are still at play" regarding the application for nonprescription sales of Plan B, a Sun-Sentinel editorial says. Von Eschenbach will have to make a decision on the application before a vote on his confirmation is held, a Sun-Sentinel editorial says, adding, "How he acts will be a telling sign of how he would lead" FDA -- "with integrity or as a political tool" (South Florida Sun-Sentinel, 8/7).

  • Salt Lake Tribune: "It's doubtful a young woman might decide to have sex based on whether or not she has ready access to Plan B" because "[t]eenage sex is more about hormones than rational thought," a Tribune editorial says. "Requiring those younger than 18 to have a prescription makes the drug legally unavailable to vulnerable girls whose lives would be most threatened by pregnancy," the editorial says, concluding, "Plan B is not an abortive drug; to the contrary, its use would prevent many abortions. Who, honestly, can oppose that?" (Salt Lake Tribune, 8/6).

Opinion Piece

  • David Ulin, Los Angeles Times: "We live in a culture that doesn't want to own up" to the fact that "tak[ing] responsibility for yourself and act[ing]" are "part of what it means to be an adult" and that "wants some vaguely parental-style authority -- God, the government, even science -- to tell us what to do," Times book editor Ulin writes in an opinion piece. "That's what the ongoing debate over reproductive freedom misses: that you can't legislate morality, that being an adult means measuring pros and cons, compromising, deciding what you can bear and what you can't," Ulin writes, adding, "In the end, it's a matter of personal, as opposed to social, conscience, a conversation we each must have with ourselves" (Ulin, Los Angeles Times, 8/7).

  • Mary Alice Carr, New York Times: It is "bewildering" that FDA's "greatest concern" in approving over-the-counter sales of Plan B is "neither medical nor scientific but rather how to keep teenagers from getting their hands on it," Carr, vice president of communications for NARAL Pro-Choice New York, writes in a Times letter to the editor. "It simply makes no sense" to "deliberately keep safe and effective means of birth control" from teenagers when "Americans overwhelmingly agree that we must reduce pregnancy" in this age group, according to Carr (Carr, New York Times, 8/8).

  • Robert Goldberg, Washington Times: Critics are planning "to hold Dr. von Eschenbach['s confirmation] hostage until they receive assurances that FDA's scientific integrity is restored," which they say can be shown by taking action on the Plan B application, Goldberg, vice president for strategic initiatives for the Center for Medicine in the Public Interest," writes in a Times opinion piece. He writes, "Capitulation to this tactic will politicize science and the FDA forever," and it will "permit any politician with a pet peeve and crackpot theory to replace his or her judgment for that of the consensus of the scientific and medical communities." Goldberg concludes that President Bush "should make von Eschenbach FDA commissioner over the ignorant objections of those that would politicize science and call it truth" (Goldberg, Washington Times, 8/7).


  • For current women's health policy news, visit the National Partnership for Women & Families' website.


    ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... .....



    About Us     Help